Tag: Astellas

Phase 3 EV-302 clinical trial : Seagen, Astellas reveal promising for PADCEV and KEYTRUDA combo

businessnewstoday- October 22, 2023

Seagen Inc. and Astellas Pharma Inc. have announced encouraging results from the Phase 3 EV-302 clinical trial, presenting PADCEV in combination with KEYTRUDA versus chemotherapy. ... Read More

Astellas Pharma to acquire stake in biotech company Taysha GeneTherapies

Raghuram Kadari- October 26, 2022

Astellas Pharma has signed an agreement to acquire a 15% stake in US-based biotech company Taysha GeneTherapies through an investment of $50 million. As part ... Read More

Astellas, Seattle Genetics bag Padcev FDA approval for advanced urothelial cancer

pharmanewsdaily- December 19, 2019

Padcev FDA approval : Astellas Pharma and Seattle Genetics have bagged accelerated approval from the US Food and Drug Administration (FDA) for Padcev (enfortumab vedotin-ejfv) ... Read More

Astellas Pharma to acquire US gene therapy company Audentes Therapeutics

pharmanewsdaily- December 8, 2019

Astellas acquisition of Audentes: Japanese pharma company Astellas Pharma has agreed to acquire US gene therapy company Audentes Therapeutics in an all-cash deal worth about ... Read More